{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:52:06Z","timestamp":1771012326565,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,2,8]],"date-time":"2004-02-08T00:00:00Z","timestamp":1076198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,2,8]],"date-time":"2004-02-08T00:00:00Z","timestamp":1076198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2004,3,1]]},"DOI":"10.1038\/ng1305","type":"journal-article","created":{"date-parts":[[2004,2,9]],"date-time":"2004-02-09T18:12:18Z","timestamp":1076350338000},"page":"257-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":227,"title":["Gene expression\u2013based high-throughput screening(GE-HTS) and application to leukemia differentiation"],"prefix":"10.1038","volume":"36","author":[{"given":"Kimberly","family":"Stegmaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth N","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra A","family":"Colavito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent R","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd R","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,2,8]]},"reference":[{"key":"BFng1305_CR1","doi-asserted-by":"publisher","first-page":"12965","DOI":"10.1073\/pnas.97.24.12965","volume":"97","author":"RT Peterson","year":"2000","unstructured":"Peterson, R.T., Link, B.A., Dowling, J.E. & Schreiber, S.L. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA 97, 12965\u201312969 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1305_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.286.5441.971","volume":"286","author":"TU Mayer","year":"1999","unstructured":"Mayer, T.U. et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971\u2013974 (1999).","journal-title":"Science"},{"key":"BFng1305_CR3","doi-asserted-by":"publisher","first-page":"38837","DOI":"10.1074\/jbc.M106779200","volume":"276","author":"CM Grozinger","year":"2001","unstructured":"Grozinger, C.M., Chao, E.D., Blackwell, H.E., Moazed, D. & Schreiber, S.L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 276, 38837\u201338843 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFng1305_CR4","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S1074-5521(01)00086-2","volume":"8","author":"PA Clemons","year":"2001","unstructured":"Clemons, P.A. et al. A one-bead, one-stock solution approach to chemical genetics: part 2. Chem. Biol. 8, 1183\u20131195 (2001).","journal-title":"Chem. Biol."},{"key":"BFng1305_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0092-8674(91)90112-C","volume":"66","author":"A Kakizuka","year":"1991","unstructured":"Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663\u2013674 (1991).","journal-title":"Cell"},{"key":"BFng1305_CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"ME Huang","year":"1988","unstructured":"Huang, M.E. et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567\u2013572 (1988).","journal-title":"Blood"},{"key":"BFng1305_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1046\/j.1365-2141.2000.01804.x","volume":"108","author":"K Seiter","year":"2000","unstructured":"Seiter, K. et al. Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemia. Br. J. Haematol. 108, 40\u201347 (2000).","journal-title":"Br. J. Haematol."},{"key":"BFng1305_CR8","first-page":"2314","volume":"46","author":"JA Sokoloski","year":"1986","unstructured":"Sokoloski, J.A., Blair, O.C. & Sartorelli, A.C. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5\u2032-phosphate dehydrogenase. Cancer Res. 46, 2314\u20132319 (1986).","journal-title":"Cancer Res."},{"key":"BFng1305_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nbt0402-353","volume":"20","author":"JM Yeakley","year":"2002","unstructured":"Yeakley, J.M. et al. Profiling alternative splicing on fiber-optic arrays. Nat. Biotechnol. 20, 353\u2013358 (2002).","journal-title":"Nat. Biotechnol."},{"key":"BFng1305_CR10","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1101\/gr.190901","volume":"11","author":"L Yang","year":"2001","unstructured":"Yang, L., Tran, D.K. & Wang, X. BADGE, Beads Array for the Detection of Gene Expression, a high-throughput diagnostic bioassay. Genome Res. 11, 1888\u20131898 (2001).","journal-title":"Genome Res."},{"key":"BFng1305_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.chembiol.2003.08.009","volume":"10","author":"DE Root","year":"2003","unstructured":"Root, D.E., Flaherty, S.P., Kelley, B.P. & Stockwell, B.R. Biological mechanism profiling using an annotated compound library. Chem. Biol. 10, 881\u2013892 (2003).","journal-title":"Chem. Biol."},{"key":"BFng1305_CR12","first-page":"1025","volume":"67","author":"AJ Bodner","year":"1981","unstructured":"Bodner, A.J., Ting, R.C. & Gallo, R.C. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J. Natl. Cancer Inst. 67, 1025\u20131030 (1981).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng1305_CR13","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/0024-3205(85)90439-4","volume":"36","author":"KA Kalinyak","year":"1985","unstructured":"Kalinyak, K.A., Sawutz, D.G., Lampkin, B.C., Johnson, C.L. & Whitsett, J.A. Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60. Life Sci. 36, 1909\u20131916 (1985).","journal-title":"Life Sci."},{"key":"BFng1305_CR14","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0024-3205(97)00126-4","volume":"60","author":"GJ Fici","year":"1997","unstructured":"Fici, G.J., Wu, H., VonVoigtlander, P.F. & Sethy, V.H. D1 dopamine receptor activity of anti-parkinsonian drugs. Life Sci. 60, 1597\u20131603 (1997).","journal-title":"Life Sci."},{"key":"BFng1305_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0014-2999(98)00896-6","volume":"366","author":"S Perachon","year":"1999","unstructured":"Perachon, S., Schwartz, J.C. & Sokoloff, P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Eur. J. Pharmacol. 366, 293\u2013300 (1999).","journal-title":"Eur. J. Pharmacol."},{"key":"BFng1305_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/08923978209031077","volume":"4","author":"GS Duncan","year":"1982","unstructured":"Duncan, G.S., Wolberg, G., Schmitges, C.J., Deeprose, R.D. & Zimmerman, T.P. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine. J. Immunopharmacol. 4, 79\u2013100 (1982).","journal-title":"J. Immunopharmacol."},{"key":"BFng1305_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/01.HYP.35.1.262","volume":"35","author":"RK Dubey","year":"2000","unstructured":"Dubey, R.K. et al. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway. Hypertension 35, 262\u2013266 (2000).","journal-title":"Hypertension"},{"key":"BFng1305_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1084\/jem.20021129","volume":"196","author":"MC Guillemin","year":"2002","unstructured":"Guillemin, M.C. et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J. Exp. Med. 196, 1373\u20131380 (2002).","journal-title":"J. Exp. Med."},{"key":"BFng1305_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0301-472X(98)00078-2","volume":"27","author":"JC Mountford","year":"1999","unstructured":"Mountford, J.C. et al. Estrone potentiates myeloid cell differentiation: a role for 17 beta-hydroxysteroid dehydrogenase in modulating hemopoiesis. Exp. Hematol. 27, 451\u2013460 (1999).","journal-title":"Exp. Hematol."},{"key":"BFng1305_CR20","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1073\/pnas.0731830100","volume":"100","author":"GJ Shim","year":"2003","unstructured":"Shim, G.J. et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. USA 100, 6694\u20136699 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1305_CR21","first-page":"586","volume":"35","author":"MW McBurney","year":"1975","unstructured":"McBurney, M.W. & Whitmore, G.F. Mechanism of growth inhibition by methotrexate. Cancer Res. 35, 586\u2013590 (1975).","journal-title":"Cancer Res."},{"key":"BFng1305_CR22","first-page":"14","volume":"1","author":"P Reyes","year":"1965","unstructured":"Reyes, P. & Heidelberger, C. Fluorinated pyrimidines. XXVI. Mammalian thymidylate synthetase: its mechanism of action and inhibition by fluorinated nucleotides. Mol. Pharmacol. 1, 14\u201330 (1965).","journal-title":"Mol. Pharmacol."},{"key":"BFng1305_CR23","first-page":"73","volume":"46","author":"N Ben-Baruch","year":"1994","unstructured":"Ben-Baruch, N. et al. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation. Mol. Pharmacol. 46, 73\u201378 (1994).","journal-title":"Mol. Pharmacol."},{"key":"BFng1305_CR24","doi-asserted-by":"publisher","first-page":"16537","DOI":"10.1073\/pnas.262420099","volume":"99","author":"K Baker","year":"2002","unstructured":"Baker, K. et al. Chemical complementation: a reaction-independent genetic assay for enzyme catalysis. Proc. Natl. Acad. Sci. USA 99, 16537\u201316542 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1305_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-5521(99)80004-0","volume":"6","author":"BR Stockwell","year":"1999","unstructured":"Stockwell, B.R., Haggarty, S.J. & Schreiber, S.L. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6, 71\u201383 (1999).","journal-title":"Chem. Biol."},{"key":"BFng1305_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0003-2697(03)00349-X","volume":"320","author":"SE Barrie","year":"2003","unstructured":"Barrie, S.E. et al. High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Anal. Biochem. 320, 66\u201374 (2003).","journal-title":"Anal. Biochem."},{"key":"BFng1305_CR27","first-page":"1293","volume":"1","author":"PH Johnson","year":"2002","unstructured":"Johnson, P.H. et al. Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Mol. Cancer Ther. 1, 1293\u20131304 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"BFng1305_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531\u2013537 (1999).","journal-title":"Science"},{"key":"BFng1305_CR29","first-page":"209","volume":"27","author":"N Mantel","year":"1967","unstructured":"Mantel, N. The detection of disease clustering and a generalized regression approach. Cancer Res. 27, 209\u2013220 (1967).","journal-title":"Cancer Res."},{"key":"BFng1305_CR30","first-page":"281","volume":"115","author":"L Harvath","year":"1999","unstructured":"Harvath, L. & Terle, D.A. Assay for phagocytosis. Methods Mol. Biol. 115, 281\u2013290 (1999).","journal-title":"Methods Mol. Biol."}],"updated-by":[{"DOI":"10.1038\/ng0404-427b","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000}},{"DOI":"10.1038\/ng0305-328a","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000}}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1305","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:05:38Z","timestamp":1684447538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3,1]]}},"alternative-id":["BFng1305"],"URL":"https:\/\/doi.org\/10.1038\/ng1305","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/ng0404-427b","asserted-by":"object"},{"id-type":"doi","id":"10.1038\/ng0305-328a","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,8]]},"assertion":[{"value":"18 December 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}